4 research outputs found
One-pot synthesis of dihalogenated ring-fused benzimidazolequinones from 3,6-Dimethoxy-2-(cycloamino)anilines using hydrogen peroxide and hydrohalic acid
3,6-Dimethoxy-2-(cycloamino)anilines
undergo 4- or 6-electron oxidations
to afford novel ring-fused halogenated benzimidazoles or benzimidazolequinones
using H2O2/HCl or H2O2/HBr. Cl2 and Br2 are capable of the same oxidative
transformation to the benzimidazolequinones. Labeling experiments
indicate that water is necessary for oxidation of the para-dimethoxybenzenes to the corresponding quinones
New oxidative transformations towards the synthesis of potential anti-cancer heterocyclic quinone and bis-quinone scaffolds
This thesis describes new oxidative transformations towards the synthesis of nitrogen-containing heterocyclic quinones.
Chapter 1 provides a review of literature published over the past decade related to heterocyclic
systems possessing a central carbocyclic ring fused onto two five-membered nitrogen-containing heterocycles, including imidazobenzimidazoles. The naming of some synthesized
fused heterocyclic systems according to IUPAC rules is derived.
Chapter 2 describes the fusion of morpholine and oxetane onto benzimidazole by oxidative
cyclization of 3,6-dimethoxy-2-(cycloamino)anilines using hydrogen peroxide with hydroiodic
acid. The cyclization serendipitously yielded 1,4,6,9-tetramethoxyphenazine as a by-product,
and reaction conditions were optimized to favour phenazine formation. Mechanisms for the HI
catalysed reactions via a detected nitroso-intermediate are proposed for the oxidative
cyclization and the unexpected intermolecular displacement of the oxazine. An aqueous
solution of molecular iodine is capable of the same transformations. Oxidative demethylation
gave targeted benzimidazolequinones, including without cleavage of the incorporated oxetane.
Chapter 3 reports the synthesis of spirocyclic oxetane-fused imidazobenzimidazoles. Oxone-mediated ring-closures to give imidazobenzimidazoles require acid and the functionalization
of 4,6-di(cycloamino)-1,3-phenylenediamines to the anilides. This is in contrast to
benzimidazole-forming oxidative cyclizations, which use 2-(cycloamino)anilines and require
no acid. New evidence for N-oxide and nitroso-intermediates in respective
imidazobenzimidazole and benzimidazole forming reactions is provided.
Chapter 4 details the synthesis of the first imidazo[4,5-f]benzimidazole iminoquinone, which
was found to be inactive against tumour cells, in contrast to the related imidazo[5,4-
f]benzimidazole isomer.
Chapter 5 discloses an optimized route to alicyclic ring-fused p-dimethoxybenzimidazole-p-benzimidazolequinone dimers. The dimers possess ambiphilicity, and a selective electrophilic
chlorination and bromination at the electron-rich p-dimethoxybenzimidazole-CH using
respectively NaCl and NaBr with Oxone in HFIP(aq), is described. The benign halide salt-oxone mix can provide tunable conditions that favour molecular halogen formation allowing
one-pot halogenation and quinone formation. In contrast, nucleophilic radical
trifluoromethylation occurs selectively at the p-benzimidazolequinone-CH with the product
subjected to one-pot chlorination and quinone formation
Incorporating morpholine and oxetane into benzimidazolequinone anti-tumor agents : the discovery of 1,4,6,9-tetramethoxyphenazine from hydrogen peroxide and hydroiodic acid-mediated oxidative cyclizations
The reactivity of hydrogen peroxide and catalytic hydroiodic acid towards 3,6-dimethoxy-2-(cycloamino)anilines is tunable to give ring-fused benzimidazoles or 1,4,6,9-tetramethoxyphenazine in high yield. Mechanisms via a detected nitroso-intermediate are proposed for oxidative cyclization and the unexpected intermolecular displacement of the oxazine. An aqueous solution of molecular iodine is capable of the same transformations. Oxidative demethylation gave targeted benzimidazolequinones, including without cleavage of the incorporated oxetane
Advances in the synthesis of ring-fused benzimidazoles and imidazobenzimidazoles
This review article provides a perspective on the synthesis of alicyclic and heterocyclic ring-fused benzimidazoles, imidazo[4,5-f]benzimidazoles, and imidazo[5,4-f]benzimidazoles. These heterocycles have a plethora of biological activities with the iminoquinone and quinone derivatives displaying potent bioreductive antitumor activity. Synthesis is categorized according to the cyclization reaction and mechanisms are detailed. Nitrobenzene reduction, cyclization of aryl amidines, lactams and isothiocyanates are described. Protocols include condensation, cross-dehydrogenative coupling with transition metal catalysis, annulation onto benzimidazole, often using CuI-catalysis, and radical cyclization with homolytic aromatic substitution. Many oxidative transformations are under metal-free conditions, including using thermal, photochemical, and electrochemical methods. Syntheses of diazole analogues of mitomycin C derivatives are described. Traditional oxidations of o-(cycloamino)anilines using peroxides in acid via the t-amino effect remain popular